Brief: Permira Funds to acquire lSNE

Clairvest

27/03/2017 13:00

March 27 (Reuters) - Clairvest Group Inc  CVG.TO : 
    * Permira Funds to acquire lSNE, a leading CDMO for the 
pharmaceutical and medical device markets, in partnership with 
management 
    * Permira -  lSNE founder, CEO  Matt Halvorsen will maintain 
a significant equity stake in company and will continue to lead 
company in his current role 
    * Permira - Claes Glassell, former CEO of CMC Biologics will 
join as chairman of board of lSNE 
    * Permira - company backed by Permira Funds has signed a 
definitive agreement to acquire lyophilization services of New 
England, Inc 
 
Source text for Eikon:  ID:nBwbnmV6Da  
Further company coverage:  CVG.TO  
 
 ((bangalore.newsroom@thomsonreuters.com;))